Day: May 12, 2020

(All amounts are stated in thousands of Canadian dollars, except per share amounts.)BRAMPTON, Ontario, May 12, 2020 (GLOBE NEWSWIRE) — Brampton Brick Limited (TSX:BBL.A) today reported a net loss of $5,968, or $0.54 per share, for the three months ended March 31, 2020, compared to net loss of $4,498, or $0.41 per share, for the corresponding quarter in 2019. The aggregate weighted average number of Class A Subordinate Voting shares and Class B Multiple Voting shares outstanding for the first quarter of 2020 and 2019 were 11,005,922 and 10,964,182, respectively.DISCUSSION OF OPERATIONSRevenues for the first quarter of 2020 were $21,029, compared to $19,356 for the same quarter of 2019. Shipments from both the Masonry Products and Landscape Products business segments increased during the months of January and February 2020 compared...

MONTREAL, May 12, 2020 (GLOBE NEWSWIRE) — (TSX-V: FRO.UN) Fronsac Real Estate Investment Trust (“Fronsac” or “the Trust”) today provided an update on the impact of the coronavirus (COVID-19) epidemic on its business.“Our team has worked relentlessly to prioritize the health and safety of our employees, tenants and our business. We continue to hold discussions with our tenants and business partners to ensure operations can continue in light of current circumstances,” said Jason Parravano, President and CEO.Fronsac’s PortfolioFronsac’s portfolio is mostly comprised of retailers who provide essential services, such as service stations, quick service restaurants, grocery stores and pharmacies. As of today, the Trust’s portfolio is comprised of 62 properties with just over 100 tenants. Throughout the COVID-19 crisis, our tenants...

MONTRÉAL, 12 mai 2020 (GLOBE NEWSWIRE) — (TSX – V : FRO.UN) Fiducie de Placement Immobilier Fronsac (« Fronsac » ou « la Fiducie ») présente aujourd’hui une mise à jour sur les impacts du Coronavirus (COVID-19) sur ses opérations.« Notre équipe a travaillé sans relâche pour prioriser la santé et la sécurité de nos employés, de nos locataires et de notre entreprise. Nous sommes en communication avec nos locataires et nos partenaires d’affaires afin d’assurer la stabilité de nos opérations malgré les circonstances actuelles. » dit Jason Parravano, président et chef de la direction.Le portefeuille de FronsacLe portefeuille immobilier de Fronsac comprend principalement des détaillants offrant des services essentiels tels que des stations-service, des établissements de restauration rapide, des épiceries et des pharmacies. À ce...

TORONTO, May 12, 2020 (GLOBE NEWSWIRE) — Firm Capital American Realty Partners Trust (the “Trust”) (TSXV: FCA.UN) (TSXV: FCA.U) is pleased to announce that it plans to file an application with the TSX Venture Exchange (the “Exchange“) to commence a normal course issuer bid (the “Bid“) to purchase up to $1,810,800 principal amount of the 6.25% convertible unsecured subordinated debentures of the Trust due June 30, 2026 (“Debentures“) (TSXV:FCA.DB), being equal to 10% of the Public Float (as defined in the policies of the Exchange) as at May 11, 2020. The Bid remains subject to the approval of the Exchange but if approved will remain in place for a period of 12 months unless terminated earlier at the Trust’s discretion.The board of trustees of the Trust is of the opinion that the recent market...

CALGARY, Alberta, May 12, 2020 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (“Peyto” or the “Company”) (TSX: PEY) herein presents its operating and financial results for the first quarter of the 2020 fiscal year. The unprecedented global pandemic which disrupted world energy demand, in combination with an untimely market share price war amongst certain OPEC+ members, led to severe commodity price volatility in the quarter. Peyto’s industry leading costs structure allowed it to preserve a 55% Operating Margin(1) however both Profit Margin(2), Return on Capital (0%) and Return on Equity (2%) were eroded due to a further 30% drop in realized commodity prices. Highlights for the quarter included:Funds from operations of $0.33/share. Generated $55 million in Funds from operations (“FFO”) in Q1 2020, down from $103 million...

TORONTO, May 12, 2020 (GLOBE NEWSWIRE) — Sprott Resource Holdings Inc. (“SRHI”) (TSX:SRHI) announced today that pursuant to a share purchase agreement entered into by Sev.en Met Coal Corp. and Sprott Resource Coal Holdings Corp. (“SRCHC”), a wholly owned subsidiary of SRHI, it disposed of 16,244,765 common shares of Corsa Coal Corp. (“Corsa”) (TSXV:CSO) at a price of $0.22 per share for aggregate gross proceeds of $3,573,848.30, subject to adjustment in certain circumstances where the purchaser acquires additional common shares of Corsa, representing all of SRHI’s interests in Corsa.Immediately prior to the closing of the disposition, based on information contained in documents publicly filed by Corsa, SRHI held, directly or indirectly, 16,244,765 common shares of Corsa, representing approximately 17.1% of Corsa’s issued and outstanding...

COPENHAGEN, Denmark, May 12, 2020 (GLOBE NEWSWIRE) — Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company”), today announced that due to current precautionary measures against the spread of the novel coronavirus (“COVID-19”), the Technical Board of Appeal (the “TBA”) of the European Patent Office (the “EPO”) has rescheduled the oral hearing of the appeal against the decision of the Opposition Division that revoked the EP2801355 patent (the “’355 Patent”). The new hearing date is February 2, 2021.About the European Intellectual Property ProceedingsOn January 29, 2018, the Opposition Division of the EPO concluded the oral proceedings concerning the ‘355 Patent (the “Opposition Proceeding”). The Opposition Division revoked the ‘355 Patent after considering oppositions from several opponents. On March 22, 2018, the Opposition...

– Preclinical data from University of Pennsylvania’s Gene Therapy Program demonstrate single injection of AAVhu68 carrying a functional GALC gene resulted in normalization of GALC enzyme activity and improved all parameters in animal models of Krabbe disease –– Treated Krabbe dogs showed nerve conduction normalization, CSF psychosine levels normalization, improved brain histopathology, phenotypic correction and increased survival –– Twitcher mouse model demonstrated peripheral nerve correction, a dose-dependent correction of phenotype and increased survival –PHILADELPHIA, May 12, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced the presentation of preclinical data for its Krabbe...

NEW HAVEN, Conn., May 12, 2020 (GLOBE NEWSWIRE) — Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Quarter1-2020 corporate update call on Tuesday, May 19th at 5:00 PM ET.The conference call may be accessed by calling 844-695-5519 (international callers dial 1- 412-902-6760).All callers should ask for the Precipio Inc. conference call. Participants may also pre-register for the conference call at http://dpregister.com/10144126 and will receive a calendar invite and a direct dial-in number, bypassing the operator.Listeners interested in submitting questions in advance should email their questions to investors@precipiodx.com and management will do its best to address those questions during the call.A replay of the call will be available approximately 24 hours after the call and may be accessed...

Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologiesMicro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRICombination of Exact Imaging’s micro-ultrasound and EDAP’s Focal One® represents the most complete offering for the focal management of prostate cancerRepresents a potentially meaningful new growth driver for EDAP LYON, France, May 12, 2020 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy based therapies, announced today that the company has signed an exclusive worldwide distribution agreement with Exact Imaging, a developer of high resolution micro-ultrasound imaging technologies. Under the terms of the agreement, EDAP will market Exact Imaging’s...